ALL LOW DOSE ASPIRIN USERS BENEFIT FROM GASTROPROTECTION: RESULTS OF A COST-UTILITY ANALYSIS OF COMPETING STRATEGIES

(1) University Medical Center Utrecht

(2) Radboud University Nijmegen Medical Center



This item was part of the Oesophageal, Gastric and Duodenal Disorders I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A158